Clinical Trial: A Prospective, Multicenter Study of Recombinant Human Thrombopoietin for Thrombocytopenia After Consolidation Chemotherapy in Children with Acute Leukemia (China)

Posted On: 2026-09-07

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Multicenter Study of Recombinant Human Thrombopoietin for Thrombocytopenia After Consolidation Chemotherapy in Children with Acute Leukemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131749

Registration Time: 2026/09/06

Type: Observational study

Primary Sponsor: Qilu Hospital of Shandong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=308195

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Prospective, Multicenter Study of Recombinant Human Thrombopoietin for Thrombocytopenia After Consolidation Chemotherapy in Children with Acute Leukemia (China)